Page results
-
This page explains the type of care we offer in the Supportive Care Unit at the University College Hospital Macmillan Cancer Centre.
-
We run two separate Urogynaecology services at UCH: the Urogynaecology and Pelvic Floor Unit and the Female Pelvic Medicine and Reconstructive Surgery Unit.
-
Information about sickle cell disorder and pregnancy for UCLH patients.
-
At your first visit to UCLH your midwife will discuss birth place options with you and recommend a place of birth.
-
This page aims to help you, your family or carers to plan ahead, and talk about decisions about your care or treatment that may need to be made in the future.
-
The flow cytometry laboratory provides a Haematological Malignancy diagnostic service which includes chronic and acute leukaemias and lymphomas.
-
Diet and nutrition advice for people experiencing weight loss, weight gain, appetite changes, difficulty eating, or other digestive problems which have happened as a result of their treatment or condition. Advice is also available for people who are confused about what diet or nutrition advice to follow.
-
Advice for University College London Hospital patients who have experienced hair loss.
-
This page gives advice for those wanting to refer patients for nuclear medicine investigations at University College London Hospitals NHS Foundation Trust. Given at the end of this page are appropriate referral guidelines for the tests we perform.
-
The Royal National ENT and Eastman Dental Hospitals is one of the UK's largest centres for ENT surgery, it offers a wide range of services from a multidisciplinary team. The ENT out-patient department provides both routine and specialist clinics including some nurse-led clinics. Referral to this service is via your GP.
File results
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis